Diagnostics-as-a-Service Market Report 2026

The diagnostics-as-a-service market size has grown exponentially in recent years. It will grow from $5.4 billion in 2025 to $6.53 billion in 2026 at a compound annual growth rate (CAGR) of 21%. The growth in the historic period can be attributed to expansion of digital health infrastructure, rising demand for cost-efficient diagnostics, growing shortage of skilled diagnostic professionals, increasing use of telemedicine services, wider adoption of cloud computing in healthcare.

The diagnostics-as-a-service market size is expected to see exponential growth in the next few years. It will grow to $13.88 billion in 2030 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to growing demand for real-time diagnostics, rising investments in ai-powered clinical decision support, expansion of remote patient monitoring, increasing focus on decentralized healthcare delivery, broader adoption of diagnostics-as-a-service models. Major trends in the forecast period include expansion of cloud-based diagnostic platforms, rising adoption of remote diagnostic services, increased integration of AI-based diagnostic tools, growing demand for scalable diagnostic infrastructure, enhanced focus on interoperable diagnostic systems.

The rising prevalence of chronic diseases is expected to drive the growth of the diagnostics-as-a-service market in the coming years. Chronic diseases are long-lasting health conditions that develop gradually and often require continuous medical attention. Their increasing occurrence is partly attributed to sedentary lifestyles, as extended periods of inactivity and limited physical exercise elevate the risk of conditions such as cardiovascular diseases and diabetes. Diagnostics-as-a-service supports chronic disease diagnosis and management by enabling cloud-based testing and analysis, which simplifies the monitoring of long-term health conditions. These services enhance care by delivering timely insights, minimizing the need for frequent hospital visits, and improving access for patients with ongoing healthcare requirements. For example, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% increase from 3,065,825 cases in 2022. As a result, the growing prevalence of chronic diseases is contributing to the expansion of the diagnostics-as-a-service market.

Leading companies in the diagnostics-as-a-service market are prioritizing the development of patient-focused solutions, including at-home laboratory testing services, to enhance convenience and accessibility. At-home lab testing services consist of diagnostic kits that allow individuals to collect samples at home and receive test results without visiting a healthcare facility. For instance, in June 2025, Amazon India, a US-based e-commerce company, partnered with Orange Health Labs, an India-based healthcare provider, to launch Amazon Diagnostics, an at-home lab testing service offered under Amazon Medical. The service is available in six major cities and provides doorstep sample collection within 60 minutes, along with digital reports delivered in as little as six hours, covering more than 800 diagnostic tests. Integrated into the Amazon app, it enables users to book tests, track progress, and securely access reports, addressing challenges related to delays, accessibility, and quality in India’s diagnostic ecosystem while supporting Amazon’s broader goal of offering end-to-end healthcare services, including pharmacy and clinical care.

In August 2024, Quest Diagnostics, a US-based provider of diagnostic information services and clinical laboratory testing, acquired LifeLabs for an undisclosed amount. Through this acquisition, Quest Diagnostics sought to broaden its diagnostics-as-a-service presence across North America by integrating its specialized laboratory services and advanced testing capabilities with LifeLabs’ community-based laboratory network and digital health infrastructure. LifeLabs is a Canada-based provider of community laboratory diagnostic services and digital health connectivity solutions.

Major companies operating in the diagnostics-as-a-service market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Invitae Corporation, InHealth Group Limited, Canon Medical Systems Corporation, Freenome Holdings Inc., BioSerenity SAS, PathAI Inc., Butterfly Network Inc., Aidoc Medical Ltd., Owkin Inc., K Health Inc.

North America was the largest region in the diagnostics-as-a-service market in 2025. The regions covered in the diagnostics-as-a-service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diagnostics-as-a-service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the diagnostics-as-a-service market by increasing costs of imported servers, networking equipment, diagnostic sensors, imaging hardware, and cybersecurity solutions required for cloud-based diagnostic platforms. Healthcare providers and diagnostic laboratories in North America and Europe are most affected due to reliance on imported digital infrastructure, while Asia-Pacific faces cost pressures on platform deployment and scaling. These tariffs are increasing subscription and service delivery costs. However, they are also promoting regional cloud infrastructure investments, domestic software development, and localized diagnostic service ecosystems that enhance system resilience and data security.

The diagnostics-as-a-service market research report is one of a series of new reports that provides diagnostics-as-a-service market statistics, including diagnostics-as-a-service industry global market size, regional shares, competitors with a diagnostics-as-a-service market share, detailed diagnostics-as-a-service market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostics-as-a-service industry. This diagnostics-as-a-service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Diagnostics-as-a-service is a cloud-enabled healthcare approach that provides diagnostic testing, analysis, and reporting through digital platforms, frequently incorporating artificial intelligence (AI), the internet of things (IoT), and remote connectivity. It supports the delivery of scalable, cost-efficient, and accessible diagnostic solutions without requiring extensive in-house infrastructure. This model facilitates real-time health monitoring, quicker clinical decision-making, and better patient outcomes by optimizing diagnostic processes across different healthcare environments.

The key components of diagnostics-as-a-service include software, services, and hardware. Software consists of cloud-based platforms that offer on-demand diagnostic testing, analysis, and reporting, supporting scalable, cost-effective, and accessible diagnostic services. These solutions can be deployed using cloud-based, on-premises, or hybrid models. Their applications cover clinical diagnostics, imaging, pathology, genomics, and other areas, and they are extensively utilized by hospitals and clinics, diagnostic laboratories, research institutions, and others.

The diagnostics-as-a-service market includes revenues earned by entities through remote diagnostic testing, laboratory analysis, sample collection and processing, cloud-based reporting, and teleconsultation for test interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.